Table 4. Antibiogram profiles of bacterial cultures, considered as resistance and susceptibility, for each antibiotic tested at baseline and week 8.
Antibiotic | Baseline | Week 8 | ||
---|---|---|---|---|
Resistance | Sensitivity | Resistance | Sensitivity | |
Amikacin | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Amoxicillin/Clavulanic acid | 1 (20.00) | 4 (80.00) | 1 (50.00) | 1 (50.00) |
Ampicillin | 2 (40.00) | 3 (60.00) | 2 (100) | 0 (0) |
Ampicillin/Sulbactam | 1 (100) | 0 (0) | 1 (100) | 0 (0) |
Aztreonam | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Ceftazidime | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Ciprofloxacin | 4 (17.39) | 19 (82.61) | 3 (100) | 0 (0) |
Colistin | 0 (0) | 1 (100) | 0 (0) | 1 (100) |
Cefazolin | 1 (20.00) | 4 (80.00) | 1 (50.00) | 1 (50.00) |
Ertapenem | 0 (0) | 5 (100) | 0 (0) | 2 (100) |
Cefepime | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Cefoxitin | 2 (40.00) | 3 (60.00) | 1 (50.00) | 1 (50.00) |
Cefotaxime | 1 (16.67) | 5 (83.33) | 1 (50.00) | 1 (50.00) |
Gentamicin | 7 (35.00) | 13 (65.00) | 1 (33.33) | 2 (66.67) |
Imipenem | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Levofloxacin | 0 (0) | 2 (100) | 0 (0) | 1 (100) |
Meropenem | 0 (0) | 1 (100) | 0 (0) | 1 (100) |
Minocycline | 1 (100) | 0 (0) | 1 (100) | 0 (0) |
Piperacillin | 0 (0) | 1 (100) | 0 (0) | 1 (100) |
Piperacillin/Tazobactam | 0 (0) | 6 (100) | 0 (0) | 2 (100) |
Trimethoprime/Sulfamethoxazole | 2 (8.70) | 21 (91.30) | 2 (66.67) | 1 (33.33) |
Tigecyline | 2 (8.70) | 21 (91.30) | 1 (33.33) | 2 (66.67) |
Clindamycin | 3 (15.00) | 17 (85.00) | 2 (100) | 0 (0) |
Erythromycin | 4 (21.05) | 15 (78.95) | 2 (100) | 0 (0) |
Habekacin | 0 (0) | 19 (100) | 0 (0) | 2 (100) |
Linezolid | 0 (0) | 20 (100) | 0 (0) | 2 (100) |
Methicillin | 8 (42.11) | 11 (57.89) | 2 (100) | 0 (0) |
Oxacillin | 8 (42.11) | 11 (57.89) | 2 (100) | 0 (0) |
Penicillin | 18 (94.74) | 1 (5.26) | 1 (100) | 0 (0) |
Teicoplanin | 0 (0) | 20 (100) | 0 (0) | 2 (100) |
Tetracycline | 6 (30.00) | 14 (70.00) | 0 (0) | 2 (100) |
Vancomycin | 0 (0) | 20 (100) | 0 (0) | 2 (100) |
Values are presented as number (%).